Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Shares Outstanding (2017 - 2026)

Equillium (EQ) posted quarterly Shares Outstanding (Entity) of $96.3 million for Q1 2026, up 169.54% year-over-year from $35.7 million in Q1 2025, and up 56.64% quarter-over-quarter from $61.5 million in Q4 2025.

Analysis

Equillium (EQ) Shares Outstanding (2017 - 2026) Analysis & Trends

Equillium (EQ) has reported Shares Outstanding (Entity) for 10 consecutive years, with $96.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 169.54% year-over-year to $96.3 million; the TTM figure through Mar 2026 stood at $96.3 million (up 169.54% YoY), while the FY2025 annual figure was $61.5 million, up 72.86% from the prior year.
  • Shares Outstanding (Entity) grew to $96.3 million in Q1 2026 per EQ's latest filing, from $61.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $96.3 million in Q1 2026 and bottomed at $34.3 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $41.7 million across 5 years, with a median of $35.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 0.4% — and 2026, when it surged 169.54%.
  • Equillium's Shares Outstanding (Entity) stood at $34.4 million in 2022, then increased by 2.44% to $35.3 million in 2023, then climbed by 0.86% to $35.6 million in 2024, then soared by 72.86% to $61.5 million in 2025, then jumped by 56.64% to $96.3 million in 2026.
  • Business Quant data shows EQ's Shares Outstanding (Entity) at $96.3 million in Q1 2026, $61.5 million in Q4 2025, and $60.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Equillium 249.33 Mn 249.33 Mn - 111.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 111.81 Mn
Mar 31, 2026 96.28 Mn
Dec 31, 2025 57.30 Mn
Sep 30, 2025 65.32 Mn
Jun 30, 2025 35.72 Mn
Mar 31, 2025 35.59 Mn
Dec 31, 2024 35.36 Mn
Sep 30, 2024 35.42 Mn
Jun 30, 2024 35.29 Mn
Mar 31, 2024 35.25 Mn
Dec 31, 2023 34.73 Mn
Sep 30, 2023 34.88 Mn
Jun 30, 2023 34.45 Mn
Mar 31, 2023 34.41 Mn
Dec 31, 2022 33.73 Mn
Sep 30, 2022 34.35 Mn
Jun 30, 2022 34.29 Mn
Mar 31, 2022 31.87 Mn
Dec 31, 2021 28.81 Mn
Sep 30, 2021 29.38 Mn